Drug Trial Radar · NCT00891735
A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)
Last checked: Nov 20, 2026Latest source record: Jan 18, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,097
Actual
Start
Jul 2009
Primary completion
Aug 2011
Study completion Aug 2012
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- May 1, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III, multicenter, randomized, double-masked, dose-comparison study of the efficacy and safety of ranibizumab injection administered intravitreally to patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). Results are presented for the first 12 months of the study.
Conditions
- Age-related Macular Degeneration
Interventions
RanibizumabDrug
Sterile solution for intravitreal injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Best Corrected Visual Acuity (BCVA) at Month 12Time frame: Baseline to Month 12
Locations
99 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Arcadia, California
Site not named
Beverly Hills, California
Site not named
Campbell, California
Site not named
Chico, California
Site not named
La Jolla, California
Site not named
Los Angeles, California
Site not named
Los Angeles, California
Site not named
Mountain View, California
Site not named
Oakland, California
Site not named
Palm Desert, California
Site not named
Poway, California
Site not named
Sacramento, California
Site not named
San Francisco, California
Site not named
San Francisco, California
Site not named
Santa Ana, California
Site not named
Santa Barbara, California
Site not named
Torrance, California
Site not named
Ventura, California
Site not named
Westlake Village, California
Site not named
Aurora, Colorado
Site not named
Colorado Springs, Colorado
Site not named
Golden, Colorado
Site not named
Danbury, Connecticut
Site not named
Hamden, Connecticut
Site not named
New Haven, Connecticut
Site not named
New London, Connecticut
Site not named
Altamonte Springs, Florida
Site not named
Boynton Beach, Florida
Site not named
Fort Lauderdale, Florida
Site not named
Fort Myers, Florida
Site not named
Palm Beach Gardens, Florida
Site not named
Pensacola, Florida
Site not named
Stuart, Florida
Site not named
Tampa, Florida
Site not named
Tampa, Florida
Site not named
Winter Haven, Florida
Site not named
Augusta, Georgia
Site not named
‘Aiea, Hawaii
Showing 40 of 99 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.